In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Пожалуйста, войдите в систему, чтобы принять участие в дискуссии (добавить собственные рецензию, или комментарий)
Цитировать эту публикацию
%0 Journal Article
%1 noauthororeditor
%A Xueting, Yao
%A Ye, Fei
%A Zhang, Miao
%A Cui, Cheng
%A Huang, Baoying
%A Niu, Peihua
%A Liu, Xu
%A Zhao, Li
%A Dong, Erdan
%A song, Chunli
%A Zhan, Siyan
%A Lu, Roujian
%A Li, Haiyan
%A Tan, Wenjie
%A Liu, Dongyang
%D 2020
%J Clinical Infectious Diseases
%K (h)cq covid-19 dosage in_vitro
%R https://doi.org/10.1093/cid/ciaa237
%T In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
@article{noauthororeditor,
added-at = {2020-04-30T19:38:01.000+0200},
author = {Xueting, Yao and Ye, Fei and Zhang, Miao and Cui, Cheng and Huang, Baoying and Niu, Peihua and Liu, Xu and Zhao, Li and Dong, Erdan and song, Chunli and Zhan, Siyan and Lu, Roujian and Li, Haiyan and Tan, Wenjie and Liu, Dongyang},
biburl = {https://www.bibsonomy.org/bibtex/2e8c772c6ca13c9a6381fa650268be0ea/fordham1},
description = {In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Clinical Infectious Diseases | Oxford Academic},
doi = {https://doi.org/10.1093/cid/ciaa237},
interhash = {abba5f4164165eefd9155c009c4a8ce6},
intrahash = {e8c772c6ca13c9a6381fa650268be0ea},
journal = {Clinical Infectious Diseases},
keywords = {(h)cq covid-19 dosage in_vitro},
month = mar,
timestamp = {2020-04-30T19:38:01.000+0200},
title = {In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)},
year = 2020
}